Navigation Links
Global Medical Device Outsourcing Industry
Date:7/17/2013

s 2004, 2012, and

2018 (includes corresponding Graph/Chart) III-31

 

3. JAPAN III-32

Market Analysis III-32

By Device Category III-32

Table 52: Japanese Recent Past, Current & Future Analysis

for Medical Device Outsourcing Services by Device Category

- Class I, Class II, and Class III Markets Independently

Analyzed with Annual Revenues in US$ Million for Years 2010

through 2018 (includes corresponding Graph/Chart) III-32

 

Table 53: Japanese Historic Review for Medical Device

Outsourcing Services by Device Category - Class I, Class

II, and Class III Markets Independently Analyzed with

Annual Revenues in US$ Million for Years 2004 through 2009

(includes corresponding Graph/Chart) III-33

 

Table 54: Japanese 15-Year Perspective for Medical Device

Outsourcing Services by Device Category - Percentage Share

Breakdown of Revenues for Class I, Class II, and Class III

Markets for Years 2004, 2012, and 2018 (includes

corresponding Graph/Chart) III-34

By Application III-35

Table 55: Japanese Recent Past, Current & Future Analysis

for Medical Device Outsourcing Services by Application -

Radiology, Orthopedic, Neurology, Cardiology, and Other

Markets Independently Analyzed with Annual Revenues in US$

Million for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-35

 

Table 56: Japanese Historic Review for Medical Device

Outsourcing Services by Application - Radiology,

Orthopedic, Neurology, Cardiology, and Other Markets

Independently Analyzed with Annual Revenues in US$ Million

for Years 2004 through 2009 (includes corresponding

Graph/Chart) III-36

 

Table 57: Japanese 15-Year Perspective for Medical Device

Outsourcing Services by Applica
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine technology :

1. Over 55 Industry Experts Expected to Attend CPhI Worldwides Pre-Connect Conference - the Pharma Industrys Leading Global Event
2. UBM Canon and Qmed, the Global MedTech Authority, Publishes New Infographic Examining OEMs and Their Suppliers
3. Global Blood Pressure Monitor Market 2012-2016: High Competition among Vendors Could Pose a Challenge to Growth of this Market
4. Global Medical Devices Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry
5. Global Dental Orthodontic Supplies Industry
6. Global Dental Restorative Supplies Industry
7. Global Antiviral Therapeutics Report - Technologies, Markets and Companies - 2013-2022
8. Global Good and AUCMA Partner to Commercialize Vaccine Storage Invention for Developing Countries
9. Lab Automation Market Report - Trends & Global Forecasts to 2017
10. Medical Disposables Market is Expected to Reach USD 193.89 Billion Globally in 2018: Transparency Market Research
11. Infection Control Market - Sterilization & Disinfection - Global forecast to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 Celtaxsys, Inc., a ... including those with rare and orphan inflammatory disease indications, ... U.S. Food and Drug Administration (FDA) to begin a ... acebilustat (CTX-4430), in adult CF patients in the US. ... Europe will be filed soon after. ...
(Date:7/6/2015)...  OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS ), ... the appointment of Joann V. Lofgren to ... Development, effective July 6, 2015. In this role, Ms. ... on the company,s market and product development strategy for ... welcome Joann to the OncoSec team and have her ...
(Date:7/4/2015)... 4, 2015 De ... chemotherapie voor patiënten met niet-resectabele uitgezaaide colorectale ... progressievrije overleving in dat orgaan. ... (mCRC) die alleen binnen de lever is ... overleving (PFS) in de lever dankzij de ...
Breaking Medicine Technology:Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 2OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5
... Mass., Aug. 14 StatSure,Diagnostic Systems, Inc. (OTC Bulletin ... patented, "barrel- test" format for the detection of,antibodies to ... completed,the trials needed for a CLIA waiver application and ... Food & Drug Administration (FDA) for,their review. The Company ...
... Efficacy of LBH589 in ... Myeloma, NORWALK, Conn., Aug. 14 The Multiple ... Phase II,study to determine the efficacy of LBH589 for ... LBH589 is an orally,administered deacetylase inhibitor developed by Novartis ...
Cached Medicine Technology:CLIA Waiver Submitted for Rapid HIV Test Employs StatSure's 'Barrel' Technology 2CLIA Waiver Submitted for Rapid HIV Test Employs StatSure's 'Barrel' Technology 3Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor 2Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor 3
(Date:7/6/2015)... , ... July 06, 2015 , ... Shortly after opening ... , the leading network of doctors working on a lien basis. Dr. Lim ... Liens. , The daughter of two Cambodian refugees, Dr. Lim suffered with back pain ...
(Date:7/6/2015)... ... July 06, 2015 , ... Invitation to ... yet there is a large gap between the unmet health priorities in the ... health outcomes and reduce unnecessary or ineffective treatments or procedures. , This milestone ...
(Date:7/6/2015)... ... , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a value of ... CAGR of over 3.2 percent in the years to come to hit the USD ... by an anticipated launch of a number of promising pipeline candidates and an increase ...
(Date:7/6/2015)... ... July 06, 2015 , ... Understanding the new ... ADVOCATE is leading the transition. ADVOCATE, the only 100% radiology, revenue cycle management ... Tips for ICD-10. The ten tips are timely and relevant guidelines to help ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... prevention in southern California, has partnered with Woodbridge Walk-In Urgent Care to offer ... stroke and other serious medical conditions. Screenings are affordable and accurate and run ...
Breaking Medicine News(10 mins):Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2
... News) -- Eating fruits and vegetables may reduce the risk ... Austrailian researchers examined the diets of 918 colorectal cancer patients ... found that consumption of certain vegetables and fruits were associated ... distal colon -- that is, the upper and lower portions ...
... AMRI (NASDAQ: AMRI) today announced the receipt of a ... its Burlington, Massachusetts aseptic finish-and-fill facility, acquired in June ... a August 2010 warning letter and a June 2011 ... AMRI, once fully implemented, should adequately address the observations ...
... are likely to change their preferences for receiving emergency ... new findings. The study, which will be ... Amsterdam today (26 September 2011), suggests that different factors ... this will often go unnoticed by their healthcare provider. ...
... and face-to-face therapy sessions for couples improve the sex ... is the finding of a new study published early ... the American Cancer Society. The results suggest that couples ... beyond those experienced from medications such as erectile dysfunction ...
... cancer survivors and their partners experience improved sexual satisfaction ... The University of Texas MD Anderson Cancer Center. The ... , a journal of the American Cancer Society, revealed ... equally effective in improving sexual outcomes. Couples on a ...
... Sweden: Results from the longest-running trial comparing tamoxifen ... letrozole has withstood the test of time and ... the risk of death in post-menopausal women with ... Gelber told delegates at the 2011 European Multidisciplinary ...
Cached Medicine News:Health News:Broccoli, Cabbage, Other Veggies May Protect Against Colon Cancer 2Health News:Study shows decisions over life-sustaining treatment are likely to change 2Health News:Couples counseling helps improve the sex lives of prostate cancer survivors and their spouses 2Health News:Couples counseling improves sexual intimacy after prostate treatment 2Health News:Couples counseling improves sexual intimacy after prostate treatment 3Health News:Couples counseling improves sexual intimacy after prostate treatment 4Health News:Aromatase inhibitor letrozole guards against breast cancer relapse for up to 8 years 2Health News:Aromatase inhibitor letrozole guards against breast cancer relapse for up to 8 years 3Health News:Aromatase inhibitor letrozole guards against breast cancer relapse for up to 8 years 4
Anti-Gliadin IgG & IgA (Ab) EIA Gastrointestinal Markers 027-GD77 Celiac Disease Food Allergy...
... OCTEIA 25-Hydroxy Vitamin D kit is an ... and other hydroxylated metabolites in serum or ... with biotin labelled 25-OH D. The diluted ... are coated with a highly specific sheep ...
... principal hormone responsible for the control of glucose ... of the islets of Langerhans as the precursor, ... insulin. Both are secreted in equimolar amounts ... molecule is comprised of two polypeptide chains, the ...
... binding Proetin (RBP) is small (21kD) transport ... with pre-albumin in blood but loses its ... deliverd to the target cells. The free,RBP ... glomerulus and catabolized in the,renal tubules after ...
Medicine Products: